Treatment of scabies
scabies treatment
scabies treatment guidelines 2024 2025 permethrin ivermectin CDC WHO
| Drug | Dose/Application | Comments |
|---|---|---|
| Permethrin 5% cream | Neck down, 8-14 hrs, repeat at 7 days | First-line; Pregnancy Cat B; resistance emerging |
| Oral ivermectin | 200 mcg/kg x2 (day 1 and 14) | First-line alternative; off-label; not in pregnancy/<15 kg |
| Benzyl benzoate 10-25% | Apply x2-3 days, repeat at 7 days | Effective, cheap; widely used in developing countries |
| Crotamiton 10% cream | Apply days 1, 2, 3, and 8 | Antipruritic; marginal efficacy |
| Precipitated sulfur 5-10% | Apply 8 hrs on days 1, 2, 3 | Safe in neonates and pregnancy; limited data |
| Lindane 1% lotion | Apply 8 hrs, repeat at 7 days | Avoid - FDA black box warning for neurotoxicity; banned in California; contraindicated <10 years, pregnancy, seizure disorders |
| Malathion 0.5% lotion | Topical | Alternative in some European guidelines (Grade C) |
| Ivermectin 1% lotion | Topical | As effective as permethrin 5% cream in some studies |
| Population | Preferred Agent | Notes |
|---|---|---|
| Pregnant women | Permethrin 5% cream | Pregnancy Cat B; sulfur 5-10% is the safest alternative |
| Neonates (<2 months) | Sulfur 5-10% in petrolatum | Permethrin relatively contraindicated |
| Infants (2 months-2 yrs) | Permethrin 5% (include face/scalp) | Avoid lindane |
| HIV/immunocompromised | Ivermectin + permethrin combined | High risk of crusted scabies |
| Children <10 years | Permethrin 5% | Lindane absolutely contraindicated |
Images of scabies rash






| Lesion | Significance |
|---|---|
| Burrow (linear/J-shaped, 1-10 mm) | Pathognomonic; best seen in web spaces, wrists |
| Papules/pustules (<5 mm) | Most common lesion; intense nocturnal itch |
| Excoriations | Due to scratching; can obscure primary lesions |
| Nodules (indurated, crusted) | Common in infants, intertriginous areas |
| Hyperkeratotic plaques | Crusted scabies; palms, soles, nails |